Graham Number Checker

Date Checked2025-12-21 23:39:18
Graham Number(PB)43.68 vs (PE)34.96
Over / Under Value Percentage23.13% vs 43.11%
Dividend Yield0.00%
Dividend DateNone
SymbolBMRN
AssetTypeCommon Stock
NameBiomarin Pharmaceutical Inc
DescriptionBioMarin Pharmaceutical Inc. is a pioneer in the development and commercialization of innovative therapies targeting rare genetic disorders and serious medical conditions, firmly positioned in the biotechnology sector. Headquartered in San Rafael, California, the company leverages advanced science and technology to create targeted treatments that address significant unmet medical needs. With a strong portfolio of approved therapies and a dedicated focus on research and development, BioMarin is poised for sustained growth and is committed to enhancing the lives of patients affected by rare diseases.
CIK1048477
ExchangeNASDAQ
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Address770 LINDARO STREET, SAN RAFAEL, CA, UNITED STATES, 94901
OfficialSitehttps://www.biomarin.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization10433730000
EBITDA794049000
PERatio20.19
PEGRatio0.65
BookValue31.53
DividendPerShareNone
EPS2.69
RevenuePerShareTTM16.16
ProfitMargin0.168
OperatingMarginTTM-0.0602
ReturnOnAssetsTTM0.0615
ReturnOnEquityTTM0.0907
RevenueTTM3094001000
GrossProfitTTM2516129000
DilutedEPSTTM2.69
QuarterlyEarningsGrowthYOY1.243
QuarterlyRevenueGrowthYOY0.041
AnalystTargetPrice89.36
AnalystRatingStrongBuy5
AnalystRatingBuy16
AnalystRatingHold5
AnalystRatingSell0
AnalystRatingStrongSell0
TrailingPE20.19
ForwardPE11.19
PriceToSalesRatioTTM3.372
PriceToBookRatio1.745
EVToRevenue3.134
EVToEBITDA12.55
Beta0.303
52WeekHigh73.51
52WeekLow50.76
50DayMovingAverage53.79
200DayMovingAverage58.96
SharesOutstanding192114000
SharesFloat190445000
PercentInsiders0.776
PercentInstitutions98.060
ExDividendDateNone
dateChecked2025-12-21 23:39:18
fresh1